您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览51

There is a dearth of prospective evidence regarding cancer of the major salivary glands. Outcomes and management of major salivary gland are based largely on retrospective series spanning many decades and changes in surgical, radiation, imaging and systemic therapy strategies and technique. We sought to report contemporary patterns of relapse and prognostic factors for major salivary gland cancer.112 patients with major salivary gland cancers underwent resection with or without adjuvant therapy between January 1997 and September 2010. Outcomes were documented with follow-up until December 2014. Survival was calculated by the Kaplan-Meier method. Log-rank test and Cox proportional hazards regression were performed with locoregional control (LRC), distant control (DC) and overall survival (OS) as the primary outcome variables.Median follow-up was 55.1 months. Rates of LRC for stage I/II and III/IV at five years were 95.7

作者:Naresh, Jegadeesh;Yuan, Liu;Roshan S, Prabhu;Kelly R, Magliocca;David M, Marcus;Kristin A, Higgins;Jeffrey M, Vainshtein;J, Trad Wadsworth;Jonathan J, Beitler

来源:Oral oncology 2015 年 51卷 8期

相似文献
知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:51
作者:
Naresh, Jegadeesh;Yuan, Liu;Roshan S, Prabhu;Kelly R, Magliocca;David M, Marcus;Kristin A, Higgins;Jeffrey M, Vainshtein;J, Trad Wadsworth;Jonathan J, Beitler
来源:
Oral oncology 2015 年 51卷 8期
标签:
Head and neck cancer Radiation therapy Salivary gland cancer
There is a dearth of prospective evidence regarding cancer of the major salivary glands. Outcomes and management of major salivary gland are based largely on retrospective series spanning many decades and changes in surgical, radiation, imaging and systemic therapy strategies and technique. We sought to report contemporary patterns of relapse and prognostic factors for major salivary gland cancer.112 patients with major salivary gland cancers underwent resection with or without adjuvant therapy between January 1997 and September 2010. Outcomes were documented with follow-up until December 2014. Survival was calculated by the Kaplan-Meier method. Log-rank test and Cox proportional hazards regression were performed with locoregional control (LRC), distant control (DC) and overall survival (OS) as the primary outcome variables.Median follow-up was 55.1 months. Rates of LRC for stage I/II and III/IV at five years were 95.7